3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one,
9 Hydroxy risperidone,
9 Hydroxyrisperidone,
9 OH risperidone,
9-hydroxy-risperidone,
9-hydroxyrisperidone,
9-OH-risperidone,
Invega,
Invega Sustenna,
paliperidone,
paliperidone palmitate,
Palmitate, Paliperidone,
R 76477,
R-76477,
R76477,
Sustenna, Invega,
Paliperidone,
144598-75-4,
9-Hydroxyrisperidone,
Invega,
9-OH-risperidone,
PALLIPERIDONE,
3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one,
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one,
R 76477,
R-76477,
CHEMBL1621,
RO-76477,
CHEBI:83804,
MFCD00871802,
4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-,
(9RS)-3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl))ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido(1,2-a)pyrimidin-4-one,
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one,
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one,
4H-Pyrido(2,1-a)pyrimidin-4-one, 6,7,8,9-tetrahydro-3-(2-(4-(6-fluro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-9-hydroxy-2-methyl-,
4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8-tetrahydro-9-hydroxy-2-methyl-,
4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-,
4H-yrido[1,2-]yrimidin-4-ne, 3-2-4-(6-luoro-1,2-enzisoxazol-3-l)-1-iperidinyl]thyl]-6,7,8,9-etrahydro-9-ydroxy-2-ethyl-,
Paliperidone [INN],
9-Hydroxy risperidone,
RO76477,
HSDB 8148,
UNII-838F01T721,
Paliperidone/Invega,
3-(2-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]ETHYL)-9-HYDROXY-2-METHYL-4H,6H,7H,8H,9H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE,
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one,
Paliperidone [USAN:INN:BAN:JAN],
Invega (TN),
Paliperidone(Invega),
9-hydroxy risperidone,
AC1L3GS8,
9-Hydroxyrisperidone, 98%,
JNS-007ER,
MLS004773953,
SCHEMBL436689,
GTPL7258,
Paliperidone (JAN/USAN/INN),
CTK8B3649,
AOB1667,
Paliperidone, >=98% (HPLC),
RAC 9-HYDROXY RISPERIDONE,
PMXMIIMHBWHSKN-UHFFFAOYSA-N,
BCPP000132,
HMS3261B06,
BCP02338,
HY-A0019,
KS-00000W1B,
Tox21_500562,
ABP000395,
AN-759,
ANW-42875,
BDBM50252513,
MFCD09955571,
s1724,
AKOS005266713,
AKOS016339656,
AKOS025392164,
AC-1282,
BCP9001047,
CCG-221866,
CM14424,
CS-0386,
DB01267,
KS-1279,
LP00562,
MCULE-5597043685,
PB27526,
RL01805,
RTC-030009,
YF10040,
NCGC00186014-01,
NCGC00261247-01,
AK-77508,
AS-13860,
BC228519,
BC677689,
S451,
SC-08807,
SMR001456280,
AB0018636,
AB1010913,
LS-134195,
TC-030009,
838F01T721,
9-Hydroxy Risperidone-d4 (Paliperidone D4),
9-Hydroxyrisperidone 1.0 mg/ml in Methanol,
FT-0080561,
FT-0600425,
P1897,
ST24030055,
C21516,
D05339,
J10457,
Q-4343,
598P754,
L023985,
SR-02000000862,
I14-1945,
Q-101425,
SR-02000000862-3,
BRD-A99888680-001-04-6,
Paliperidone, United States Pharmacopeia (USP) Reference Standard,
(+/-)-3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one,
(9RS)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (9-Hydroxyrisperidone),
3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one,
3-[ 2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one,
3-[ 2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin4-one,
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one,
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, 9-Hydroxyrisperidone,
3-[2-[4-(6-Fluoro-1,2-Benzisoxazol-3-yl)-1-Piperidinyl]Ethyl]-9-Hydroxy-6,7,8,9-Tetrahydro-2-Methyl-4H-Pyrido[1,2-a]-Pyrimidin-4-One,
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one,
3-[2-[4-(6-FLUOROBENZO[D]ISOXAZOL-3-YL)-1-PIPERIDYL]ETHYL]-7-HYDROXY-4-METHYL-1,5-DIAZABI-CYCLO[4.4.0]DECA-3,5-DIEN-2-ONE,
3-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)-1-piperidinyl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-alpha]pyrimidin-4-one,
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one,
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-9-hydroxy-2-methyl-6,7,8,9- tetrahydro-pyrido[1,2-a]pyrimidin-4-one,
6,7,8,9-Tetrahydro-3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-9-hydroxy-2-methyl-4H-pyrido[2,1-a]pyrimidin-4-one,
6,7,8,9-Tetrahydro-3-(2-(4-(6-fluro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-9-hydroxy-2-methyl-4H-pyrido[2,1-a]pyrimidin-4-one,
9-Hydroxyrisperidone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,
Invega Sustenna,
xeplion,
Paliperidone-d4,
9-Hydroxy-risperidone,
Sustenna, Invega,
9 OH risperidone,
Paliperidone Palmitate,
9 Hydroxyrisperidone,
9 Hydroxy risperidone,
Palmitate, Paliperidone,
D0B3UJ,
C23H27FN4O3,
HSDB 5716,
JNS-010,
C23-H27-F-N4-O3,
CID115237,
Ro-92670,
ACN-050765,
CS-O-02070,
RO 76477,
Paliperidone (depot injection, NanoCrystal),
Paliperidone (injectable, NanoCrystal), Elan,
R76477,
C079150,
D000068882,
Paliperidone (depot injection, NanoCrystal), Johnson & Johnson,
Paliperidone, 99%, a potent D2 and 5-HT2A antagonist - 10MG 10mg,
1020719-55-4,
199739-10-1,
3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one,